Drug Trials Snapshots
fda.gov·27m
Preview
Report Post
Drug Trials Snapshot: LYNOZYFIC
fda.gov·35m
Preview
Report Post
Competitive Generic Therapy Approvals
fda.gov·2h
Preview
Report Post
Novel Drug Approvals for 2025
fda.gov·2h
Preview
Report Post
Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act
fda.gov·3h
Preview
Report Post
Verified Clinical Benefit | Cancer Accelerated Approvals
fda.gov·5h
Preview
Report Post
Ongoing | Cancer Accelerated Approvals
fda.gov·5h
Preview
Report Post
GDUFA Type II API DMF Payment Receipts Report
fda.gov·20h
Preview
Report Post
Generic Drug User Fee Amendments
fda.gov·21h
Preview
Report Post
Bayesian Statistical Analysis (BSA) Demonstration Project
fda.gov·23h
Preview
Report Post
What's New Related to Drugs
fda.gov·1d
Preview
Report Post
Health Fraud Scams
fda.gov·1d
Preview
Report Post
Oncology (Cancer)/Hematologic Malignancies Approval Notifications
fda.gov·1d
Preview
Report Post
FDA grants traditional approval to pirtobrutinib for chronic lymphocytic leukemia and small lymphocytic lymphoma
fda.gov·1d
Preview
Report Post
Radioactive Drug Research Committee (RDRC) Program
fda.gov·1d
Preview
Report Post
What are the Qualifications and Requirements of RDRC Membership?
fda.gov·1d
Preview
Report Post
What Information Does the RDRC Review?
fda.gov·1d
Preview
Report Post
GDUFA Paid Facilities List
fda.gov·1d
Preview
Report Post
CDER Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality (CDER Quality Standards Program)
fda.gov·1d
Preview
Report Post
Newly Added Guidance Documents
fda.gov·1d
Preview
Report Post